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Introduction
In response to severe trauma or infectious injury, the den-
tine–pulp complex possesses a natural regenerative ability 
leading to the rapid deposition of a mineralised matrix at 
the dentine–pulp interface, immediately below the site of 
injury, with a primary function to protect the dental pulp 
from the effects of further insult. This reparative dentine 
histologically represents an amorphous tissue, with some 
resemblance of osseous tissue and hence is often also 
termed ‘osteodentine’. The key biological principles under-
pinning the reparative process essentially follows a wound 
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repair process involving the recruitment and proliferation 
of dental pulp stem or progenitor cells (DPSCs) and their 
subsequent differentiation to what are regarded as odonto-
blast-like cells which synthesise the mineralised tissue.1 
The process is complex and still not fully understood in 
terms of the molecular signals, but a range of growth fac-
tors and other bioactive molecules releasable from dentine 
matrix have been suggested as important contributors in 
stimulating repair. Harnessing this natural repair process 
offers a novel potential for demineralised dentine matrix 
(DDM) to be utilised therapeutically to enhance dentine 
regeneration to improve longevity of dental tooth restora-
tions and for bone augmentation applications.
Recent proteomic analyses of dentine tissue samples 
have identified between 179 and 289 different protein com-
ponents.2–4 This has included the definitive identification of 
transforming growth factor beta 1 (TGF-β1) as a predomi-
nant growth factor. The importance of TGF-β1 in the regen-
erative process has been indicated in previous work where 
crude TGF-β1-based alginate hydrogels were found to 
induce de novo dentinogenesis on a cut pulp tissue surface.5 
Studies have also shown the capacity of bone morphoge-
netic proteins (BMPs), BMP-2, BMP-46 and BMP-77 to up-
regulate dentine matrix synthesis and secretion. However, 
when used in single growth factor therapy, supraphysiolog-
ical quantities of proteins are required to illicit biological 
responses. It is now well recognised that a ‘cocktail’ of 
growth factors acting synergistically and at nanogram lev-
els is responsible for co-ordinating the reparative events in 
vivo. Also identified in dentine, are growth factors, such as 
fibroblast growth factor (FGF), FGF-2, FGF-4 or FGF-10, 
insulin-like growth factor (IGF) and vascular endothelial 
growth factor (VEGF), which have collectively been impli-
cated in the recruitment and differentiation of mesenchy-
mal stem cells (MSCs) towards an odontoblast or osteoblast 
lineage, in addition to stimulating endothelial cells angio-
genesis.5,8–11 The identification within the dentine matrix of 
pro-inflammatory cytokines, including interleukin (IL)-2, 
IL-6 and IL-8, and anti-inflammatory cytokines, IL-4 and 
IL-10,12 supports proposals that DDM may also have a role 
in supporting the inflammatory process necessary for initi-
ating tissue regeneration. The dentine matrix is also well 
characterised with respect to non-collagenous components, 
which include the small leucine-rich proteoglycans 
(SLRPs), decorin and biglycan, which have been proposed 
to sequester and protect the growth factors from proteolysis 
and have purported roles for indirectly modulating cell sig-
nalling.13–18 Equally, matrix proteins such as dentine sialo-
protein, dentine phosphoprotein, bone sialoprotein (BSP), 
osteopontin (OPN), dentine matrix protein-1 (DMP-1) and 
matrix extracellular phosphoglycoprotein (MEPE) are all 
identifiable within the matrix with various proposed sig-
nalling roles in the early reparative events influencing cell 
survival, cell differentiation and regulating mineral deposi-
tion.19 The dentine matrix also contains matrix metalopro-
teinases (MMP-2, -8, -9, -13 and -20) which have been 
suggested to enhance bioactivity through proteolytic acti-
vation of growth factors and signalling molecules such as 
DMP-1.19 MMP-2 and MMP-3 have been reported to form 
complexes with BSP and OPN, respectively,20 enhancing 
proteolytic activity and degradation products of the extra-
cellular matrix (ECM) may partake in stimulating immune 
responses which subsequently initiate wound repair.21
While proteomic studies demonstrate a bioactive poten-
tial for DDM, only a handful of studies have demonstrated 
its ability to stimulate DPSC populations to synthesise a 
mineralised matrix. In vitro, lyophilised DDM has been 
shown to mediate dental papilla cell differentiation,22 and 
soluble extracts from whole teeth have been shown to 
stimulate mineralised matrix formation by heterogeneous 
populations of DPSC.3 Similarly, in vivo studies have 
demonstrated increased dentine secretions around dentine 
chips placed in the pulp chamber23 and by soluble tooth 
extracts placed in rat tooth socket24 or incorporated into 
embryonic tooth buds transplanted under the renal capsule 
of mice.3 Similar studies have also demonstrated its poten-
tial to considerably stimulate bone repair in vivo in a rabbit 
critical size defect.25 However, it is now well recognised 
that the resident DPSC population is heterogeneous in 
nature. Studies on clonal populations expanded from sin-
gle cells have indicated populations within two extremes: 
cells with high colony-forming efficiency, long-term pro-
liferative capacity and multi-potency for lineage differen-
tiation, including osteogenesis, chondrogenesis and 
adipogenesis, and cells with limited proliferative lifespan 
and restrictive differentiation for a specific lineage such as 
osteogenesis.26–28 The various populations are proposed to 
yield different responses in wound repair process, although 
exact contributions remain undefined. Significantly, diver-
sity in the heterogeneous profile is predicted between 
donor tissue sources which have the potential to impact in 
direct comparison of results and in identifying a clear 
assessment of biological behaviour. Against this back-
ground, the aim of this study is to investigate the effect of 
a DDM protein extract derived from human teeth on a 
clonal population of DPSCs. To provide greater compe-
tency in the results, a clonal population, characterised by 
substantial immature or embryonic characteristics, high 
proliferative capacity and multi-potency, was selected for 
use in the study. This provided the baseline characteristics 
of a cell population for better assessment of biological 
roles for DDM in stimulating cell migration, expansion, 
survival and driving osteoblastic differentiation, as prereq-
uisites for the dentine repair process.
Methods and materials
Preparation of DDM
DDM was prepared from extracted healthy human teeth 
obtained from the Oral Surgery Department at the 
Birmingham Dental Hospital, collected along with patient 
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informed consent for preparation of DDM prior to 2004 
Human Tissue Act, United Kingdom. Teeth were sectioned 
down the buccal–lingual plane; pulpal tissue was extir-
pated; and cementum, enamel and carious tissue were 
removed with a slow-speed dental hand piece with a dia-
mond-tipped burr. Remnant dentine was powdered using a 
ball mill in liquid nitrogen and then treated with 10% eth-
ylenediaminetetraacetic acid (EDTA) (pH 7.2), containing 
protease inhibitors, 1 mM iodoacetic acid, 5 mM n-ethyl-
malemide and 5 mM benzamidine HCl at 4°C for 14 days, 
to solubilise non-collagenous proteins and soluble colla-
gens as the tissue demineralised. Every 2 days, the EDTA 
extractant was recovered by centrifugation at 1000g for 
10 min, and the residual dentine matrix was retreated with 
further EDTA. All protein extracts were pooled, and the 
EDTA and protease inhibitors were removed by exhaustive 
dialysis against double distilled water, and the DDM was 
recovered by lyophilisation. For a sample of DDM, non-
collagenous and collagenous proteins were removed or 
denatured to provide a negative control (DDM-neg). A 
total of 100 µg DDM powder was denatured with 100 µL 
4 mg/mL collagenase or dispase (Roche Applied Science, 
United Kingdom) at 37°C for 1 h. The DDM-neg was 
exhaustively dialysed against double distilled water at 4°C 
and lyophilised. DDM-neg was reconstituted in 1 mL of 
basal alpha Minimum Essential Medium (α-MEM) to pro-
duce a concentration equivalent to 100 µg/mL of DDM 
before denaturation.
Isolation of DPSC clones
Human third molars (18–35 years old) were obtained from 
patients attending the School of Dentistry, University 
Hospital of Wales, Cardiff, United Kingdom. Local ethical 
committee approval was obtained for this study from the 
South East Wales Research Ethics Committee of the 
National Research Ethics Service (NRES), UK Ref 12/
WA/0107, approving the process for obtaining and record-
ing written consent within the School of Dentistry, Cardiff, 
United Kingdom. Outer surfaces were sterilised with 
industrial methylated spirits (IMS) for 10 s. Teeth were 
split laterally, and exposed pulps were immediately 
extracted and incubated with 4 mg/mL collagenase or dis-
pase (Roche Applied Science) for 1 h at 37°C. Enzymic 
activity was stopped by the addition of 5–10 mL basal α-
MEM (supplemented with ribonucleosides and deoxyribo-
nucleosides; Gibco, Invitrogen, United Kingdom); 20% 
heat-inactivated foetal calf serum (hi-FCS; Invitrogen); 
4 mM l-glutamine (Gibco); 100 µM l-ascorbate 2-phos-
phate (Sigma–Aldrich, United Kingdom); and 100 units/
mL penicillin G sodium, 0.1 µg/mL streptomycin sulphate 
and 0.25 µg/mL amphotericin (Gibco). Cells were passed 
through a 70-µm cell strainer (BD Falcon, United 
Kingdom) and then twice pelleted by centrifugation at 
400g, for 5 min and resuspended in the serum-free basal 
α-MEM to ensure removal of enzyme and serum.
Immature progenitor cells expressing high surface lev-
els of functional β1 integrin were selected by differential 
fibronectin adhesion as previously described by 
Waddington et al.29 and Dowthwaite et al.30 Briefly, cells 
in serum-free media, were seeded onto fibronectin-coated 
six-well plates at 4 × 103 cells/cm2 for 20 min at 37°C. Non-
adherent cells were removed, and adherent cells were 
allowed to form single-cell colonies by continued culture 
in the serum supplemented basal α-MEM at 5% CO2 and 
37°C. Colonies of >32 cells were dissociated with 50 µL 
trypsin enclosed within the cloning ring and seeded into a 
96-well plate. Cells were passaged on reaching 80%–90% 
confluency, maintaining a reseeding density of 5 × 103/
cm2, and culture expanded into larger T75 flasks. 
Population doublings (PDs) were calculated from cell 
counts at each passage using the formula PD = (log10 (total 
cell count obtained) − log10 (total cell count re-seeded/
log10 (2)). Analyses described below were performed at 
21–24 PDs.
Reverse transcriptase–polymerase chain 
reaction
Reverse transcriptase–polymerase chain reaction 
(RT-PCR) was used to indicate gene expression of mesen-
chymal and embryonic stem cell markers and osteogenic, 
adipogenic and chrondrocytic differentiation makers. Total 
cellular RNA was extracted from cells using a Qiagen 
RNeasy Mini kit (Qiagen Ltd, United Kingdom) according 
to manufacturer’s protocol, and quantity and purity of 
RNA was determined by absorbance at 260 or 280 nm. 
Complementary DNA (cDNA) was synthesised using 1 µL 
Moloney murine leukaemia virus (M-MLV) reverse tran-
scriptase, 0.625 µL of RNasin, 1.25 µL of 10 mM deoxynu-
cleotide triphosphates (dNTPs; all Promega, United 
Kingdom) at 25°C for 10 min, 37°C for 1 h, followed by 
95°C for 5 min. Polymerase chain reactions (PCRs) were 
performed using GoTaq Flexi DNA polymerase, dNTPs, 
relevant reverse and forward primer sequences (as detailed 
in Table 1) and the following cycling conditions: initial 
denaturation at 94°C for 5 min; 40 cycles of denaturing, 
annealing and extension at 94°C for 1 min, 62°C for 30 s 
and 72°C for 1 min, respectively; and final extension at 
72°C for 10 min. RT-PCR products were separated by elec-
trophoresis on 1.5% agarose gels containing ethidium bro-
mide and viewed under ultraviolet (UV) light. β-Actin was 
used as a housekeeping gene for RT-PCR.
Adipogenic differentiation of DPSC clonal cells
Cells, at 24 PDs and 80%–90% confluency, were cultured 
in 5% CO2 at 37°C following the sequence 72 h in α-MEM, 
10% hi-FCS, 10 µg/mL insulin, 1 µM dexamethasone, 
100 µM indomethacin and 100 µM 3-isobutyl-1-methylx-
anthine (IBMX) with antibiotics or antimycotics (adipo-
genic induction media) followed by 24 h in α-MEM, 10% 
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Table 1. Forward and reverse primer sequences used in RT-PCR reactions.
RT-PCR primer Sequence (5’–3’) Anneal temperature (°C) Product size (bp)
CD105 FWD: GAAGGGCTGCGTGGCTCAGG 55 483
 RVS: CCTTCCAAGTGGCAGCCCCG  
CD146 FWD: CGACAACGGGGTCCTGGTGC 55 321
 RVS: CAGCGATAGCCGCCTCCTGC  
MSX-1 FWD: GAAGCCCGAGAGGACCCCGT 55 410
 RVS: AGGCACCGTAGAGCGAGGCA  
P75/CD271 FWD: CTGCAAGCAGAACAAGCAAG 55 310
 RVS: GGCCTCATGGGTAAAGGAGT  
Slug FWD: GAGCATACAGCCCCATCACT 55 479
 RVS: CTCCCCCGTGTGAGTTCTAA  
Snai1 FWD: GCGAGCTGCAGGACTCTAAT 55 441
 RVS: CCAGGCTGAGGTATTCCTTG  
Twist 1 FWD: GTCCGCAGTCTTACGAGGAG 55 711
 RVS: GATGCCTTTCCTTTCAGTGG  
hTERT FWD: CGGAAGAGTGTCTGGAGCAA 55 145
 RVS: GGATGAAGCGGAGTCTGGA  
hTR FWD: CTAACCCTAACTGAGAAGGGCGTA 55 154
 RVS: GGCGAACGGGCCAGCAGCTGACATT  
Oct4(a) FWD: AGGAGTCGGGGTGGAGAG 55 250
 RVS: CGTTTGGCTGAATACCTTCC  
Nanog FWD: CAAAGGCAAACAACCCACTT 55 432
 RVS: CAGGACTGGATGTTCTGGGT  
Notch 1 FWD: CTACCTGTCAGACGTGGCCT 55 356
 RVS: CGCAGAGGGTTGTATTGGTTCG  
Notch 2 FWD: AAGCAGAGTCCCAGTGCCTA 55 172
 RVS: CAGGGGGCACTGACAGTAAT  
Notch 3 FWD: CAGTCGCCTGAGAATGATCAC 55 195
 RVS: GAATGACCAGCAGCAAGACAG  
Jagged 1 FWD: GACTCATCAGCCGTGTCTCA 55 190
 RVS: CTGGGGAACACTCACACTCAA  
Jagged 2 FWD: CTACAATGGTGGCATCTGTG 52 156
 RVS: GCGATACCCGTTGATCTCAT  
Osteocalcin FWD: GCAGGTGCGAAGCCCAGCGGTGCAGAG 62 341
 RVS: GGGCTGGGAGGTCAGGGCAAGGGCAAG  
Bone sialoprotein FWD: GGGCTATGGAGAGGACGCCACGCCTGG 62 340
 RVS: CGAGGTGCCCTTGCCCTGCCTTCCGGTC  
Sox9 FWD: GTGAACTGGCCACCCCGCGCCTTCCTA 62 936
 RVS: CAGCCTTGCCCGGCTGCACGTCGGTTT  
Type 2 collagen FWD: GGCTGGCAGCTGTGTGCAGGATGGGCA 62 930
 RVS: GCGCCAGCAGGGCCAGTCCGTCCTCTT  
Lipoprotein lipase (LPL) FWD: GCTGGCATTGCAGGAAGTCTGACCAATAAG 56 621
 RVS: GGCCACGGTGCCATACAGAGAAATCTCAAA  
PPAR-γ2 FWD: GCCATCAGGTTTGGGCGGATGCCACAG 62 349
 RVS: CCTGCACAGCCTCCACGGAGCGAAACT  
Caspase 3 FWD: GTTTGTGTGCTTCTGAGCCA 55 350
 RVS: TCAAGCTTGTCGGCATACTG  
Akt1 FWD: GTGCCACCATGAAGACCTTT 55 459
 RVS: CATCTTGGTCAGGTGGTGTG  
β-Actin FWD: AGGGCAGTGATCTCCTTCTGCATCCT 65 480
 RVS: CCACACTGTGCCCATCTACGAGGGGT  
RT-PCR: reverse transcriptase–polymerase chain reaction; FWD: forward; RVS: reverse.
β-Actin was used as a housekeeping gene.
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hi-FCS, 10 µg/mL insulin and antibiotics or antimycotics 
(adipogenic maintenance media) for four rotations (total: 
16 days) before culturing cells in adipogenic maintenance 
media for a final 7 days.23 Cells cultured in the basal α-
MEM were used as a negative control. Cells were stained 
with Oil Red O and viewed under a light microscope. 
Cultures were also prepared to examine messenger RNA 
(mRNA) expression levels for lipoprotein lipase (LPL) 
and peroxisome proliferator-activated receptor gamma-2 
(PPAR-γ2) by RT-PCR.
Chondrogenic differentiation of DPSC clonal 
cells
A total of 2.5 × 105 cells (at 24 PDs) were pelleted in a 
15-mL polypropylene conical base tubes (Falcon, United 
Kingdom) by centrifugation at 150g for 5 min and then 
cultured in 1 mL non-haematopoietic (NH) stem cell media 
ChondroDiff medium (Miltenyi Biotec, United Kingdom) 
at 5% CO2 and 37°C. As a negative control, cells were cul-
tured in the basal α-MEM media. After 24 days, pellet cul-
tures were fixed overnight in neutral-buffered formalin, 
dehydrated by passing through ascending alcohol concen-
trations and paraffin wax embedded. A total of 5-µm sec-
tions were prepared on poly-l-lysine–coated glass slides. 
Sections were deparaffinised with xylene and rehydrated 
and treated with 0.15 U/mL chondroitinase ACII 
(SeikaGaku Kogyo Co., Japan), Tris acetate, pH 8, for 
30 min at 37°C to reveal digested neo-epitopes. Sections 
were blocked with 1% bovine serum albumin (BSA) and 
Tris-buffered saline (TBS) for 30 min and then incubated 
with monoclonal immunoglobulin G (IgG) antibody 2-B-6 
(detects chondroitinase neo-epitopes; dilution 1:500; gift 
from B. Caterson, Cardiff University, United Kingdom) 
for 1 h. Immuno-reactivity was detected with goat anti-
mouse IgG-fluorescein isothiocyanate (FITC; dilution 
1:200; Santa Cruz Biotechnology, Inc, Texas, USA) for 
45 min. Nuclear material was stained with bisbenzimide. 
Cell cultures were also established to examine mRNA 
expression for Sox9 and type 2 collagen by RT-PCR.
Osteogenic differentiation of DPSC clonal cells
Cells at 24 PDs were seeded at 2200 cells/cm2 on round 
glass slides in six-well plates and cultured for 23 days in 
the above basal α-MEM supplemented with 10 nM dexa-
methasone and 100 µM β-glycerolphosphate (both from 
Sigma–Aldrich, United Kingdom) at 5% CO2 and 37°C. 
Cells cultured in the absence of dexamethasone and 
β-glycerolphosphate served as a negative control. For 
some cultures (n = 3), cells were stained with 20 g/L 
Alizarin Red, pH 4.2 for 2–5 min. Cultures were also pre-
pared to examine mRNA levels for osteocalcin (OCN) and 
BSP by RT-PCR.
Influence of DDM on cell expansion
Clonal DPSCs (21–24 PDs) were seeded into 96-well 
plates at 1.5 × 104 cells/cm2 and cultured in 200 µL basal 
α-MEM overnight at 37°C and 5% CO2. Media was then 
replaced with 200 µL basal α-MEM supplemented with 
0–10 µg/mL DDM or 0–10 µg/mL DDM-neg (concentra-
tions equivalent to the DDM before denaturation) served 
as a negative control. Media was refreshed every 24 h. At 
24, 48 and 72 h, cells were fixed overnight at 4°C in 70% 
ethanol and then stained with 0.1% crystal violet (BDH 
Laboratory Supplies, United Kingdom), 0.1 M borax, 2% 
ethanol, pH 9 for 1 h with gentle agitation, rinsed well with 
water and counted when viewed under a light microscope. 
Counts were obtained from triplicate wells, and the assay 
was repeated on three separate occasions.
Influence of DDM on cell apoptosis
Clonal DPSCs at 20–24 PDs were seeded into 96-well 
plates at 1.5 × 104 cells/cm2 and cultured in 200 µL of the 
DDM, DDM-neg supplemented or unsupplemented α-MEM 
as described above. After 24, 48 and 72 h, apoptosis was 
measured using the Caspase-Glo 3/7 Assay (Promega, 
United Kingdom) following the manufacturer’s protocol. 
The assay was performed in triplicate on three separate 
occasions. Cell cultures were also established to examine 
mRNA expression for caspase 3, Akt1 and proliferating 
cell nuclear antigen (PCNA) by RT-PCR.
Influence of DDM on DPSCs migrating into 
collagen gels
Collagen gels (1 mg/mL final concentration) were pre-
pared by mixing 1.79 mL liquid rat tail collagen I (supplied 
as 3.91 mg/mL in 0.02 N acetic acid; BD Biosciences, 
United Kingdom) with 5.17 mL of the above serum sup-
plemented α-MEM. Gels contained either DMP or DMP-
neg 0–10 µg/mL (final concentration). pH was neutralised 
with 41 µL of 1 N NaOH, and 1 mL gel mixture was imme-
diately transferred into 12-well tissue culture plates to 
solidify overnight. A total of 400 µL of basal α-MEM was 
layered onto the surface of each gel, and tissue culture 
inserts with 8-µm pore membranes (Greiner Bio-One Ltd, 
Glasgow, UK) were placed into the wells in contact with 
the collagen gels. DPSCs at 20–24 PDs were immediately 
seeded into the well insert at 1 × 104/cm2 in unsupple-
mented α-MEM and cultured at 37°C and 5% CO2. After 
24 and 72 h, gels were fixed with 4% paraformaldehyde 
for 30 min and then permeated with 0.3% triton-X 100 
for 30 min. Gels were washed with TBS prior to staining 
with phalloidin-FITC (Sigma–Aldrich) in 1% BSA or TBS 
at 4°C for 1 h. Cell nuclear material was stained with 
bisbenzimide (Sigma–Aldrich) for 30 min at 4°C and then 
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washed gels were viewed by fluorescence microscopy. 
Bisbenzimide-stained nuclei were automatically counted 
using ImageJ software to obtain cell counts. Cell counts 
were obtained from five random fields of view (10× mag-
nification) from triplicate wells for each experimental con-
dition. Depth of migration was assessed from Z-stacks of 
gels viewed by confocal microscopy.
Influence of DDM on osteoblast differentiation
DPSCs at 20–24 PDs were seeded into six-well plates at 
2200 cells/cm2 and cultured in 0 or 10 µg/mL DDM, sup-
plemented or unsupplemented α-MEM as described in the 
above section. After 3, 10 and 21 days, total mRNA was 
isolated from the cells, and cDNA was synthesised as 
described above. mRNA levels for OPN and alkaline phos-
phatase was quantified by quantitative PCR (qPCR) using 
SYBR Green JumpStart Taq readymix following the man-
ufacturer’s protocol, using the forward and reverse primers 
as detailed in Table 2. For all qPCR analyses, glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) was used as 
the housekeeping gene for relative quantification. In a 
separate experiment, cells were cultured for 5 and 20 days 
in the presence and absence of 10 µg/mL DDM and stained 
with Alizarin Red for 5 min.
Statistical analysis
Where applicable, average values and standard error of 
mean (SEM represented as ±) were determined using sta-
tistical software GraphPad Instat. In order to analyse dif-
ferences between the various supplementation conditions, 
values obtained were compared using analysis of variance 
(ANOVA) with a post hoc Tukey–Kramer multiple com-
parisons test. p-values of <0.05 were considered statisti-
cally significant at a 95% confidence interval.
Results
Characterisation of clonal DPSC population
Immature mesenchymal progenitor cells were selected by 
preferential adhesion to fibronectin over a 20-min incuba-
tion time. Low-density seeding allowed clonal colonies to 
develop over a 12-day culture period. Isolated clonal col-
onies were culture expanded and one clone, designate 
hFNA3, was selected for this investigation following the 
definitive identification of MSC characteristics (Figure 
1). This particular clone demonstrated an extensive prolif-
erative lifespan beyond 325 PDs (Figure 1(a)). Following 
establishment of sufficient cell numbers of the clone in 
culture and at 21 PDs, hFNA3 expressed a triplicate of 
mesenchymal markers, CD105, CD146 and MSX-1 and 
neural crest markers of p75, slug, snai1 and twist (Figure 
1(b)). The embryonic nature of the isolated clone was fur-
ther demonstrated by expression of Oct4a and Nanog. The 
presence of these mesenchymal, neural crest and embry-
onic markers in whole pulp is shown as a positive control, 
demonstrating the presence of a similar clonal population 
within the heterogeneous MSC populations of the original 
pulpal tissue. Telomerase reverse transcriptase in humans 
(hTERT) was not detected in either the clonal population 
or the whole pulpal tissue, although its RNA encoding 
domain hTR was expressed. Early developmental mark-
ers, notch receptors Notch 1, 2 and 3, with associated 
ligands Jagged 1 and 2 were also expressed. Cells follow-
ing 106 PDs failed to express any of the stem cell markers 
analysed but did retain expression for Notch 1 and 3 and 
Jagged 1 and 2 (Figure 1(b)). Based on these results, 
multi-potency was assessed for hFNA3 clonal cells at 24 
PDs (Figure 1(c)–(e)). Culture of DPSCs in adipocytic 
media for a total of 23 days resulted in the induction of 
PPAR-γ2 mRNA (Figure 1(c)). LPL mRNA was not 
detected, while low levels were detected in the adipocyte 
positive control, possibly indicating that the DPSCs had 
not achieved full differentiation. However, adipocytes 
exhibited Oil Red O–positive lipid-filled vacuoles. 
Following culture of DPSCs in chondrocytic media for 
24 days, strong expression for type 2 collagen and Sox 9 
mRNA was apparent (Figure 1(d)). Immunocytochemistry 
indicated high staining for chondroitin sulphate around 
cells indicative of high levels of proteoglycan synthesis 
(Figure 1(d)). Following culture in osteogenic media for 
23 days, an osteoblast phenotype was identified as deter-
mined by mRNA expression of OCN and BSP, and the 
initial formation of mineralising foci which stained with 
Alizarin Red (Figure 1(e)).
Table 2. Forward and reverse primer sequences used in qPCR reactions.
qPCR primers Sequence (5’–3’) Annealing temperature (°C) Product size (bp)
Osteopontin FWD: ATCACCTGTGCCATACCA 55 430
 RVS: CATCTTCATCATCCATATCATCCA  
Alkaline phosphatase FWD: GGACCATTCCCACGTCTTCAC 55 137
 RVS: CCTTGTAGCCAGGCCCATTG  
GAPDH FWD: GGTCGGAGTCAACGGATT 55 253
 RVS: ATCGCCCCACTTGATTTTG  
GAPDH: glyceraldehyde-3-phosphate dehydrogenase; qPCR: quantitative PCR; FWD: forward; RVS: reverse.
GAPDH was used as a housekeeping gene.
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Influence of DDM on DPSC cell viability and 
apoptosis
The addition of DDM to the culture media induced a sig-
nificant increase in the number of viable cells (Figure 
2(a)), with all concentrations analysed demonstrating sig-
nificant differences in cell numbers at 72 h compared with 
the unsupplemented control (p < 0.001). The effect of 
DDM on cell expansion was dose dependent. As a nega-
tive control, supplementation with DDM-neg, where the 
protein matrix had been proteolytically degraded, indi-
cated that stimulatory activity of the DDM had been abol-
ished. At all concentrations examined (equivalent to the 
starting concentration of the DDM), there was no differ-
ence in the expansion of viable cell numbers compared 
with the unsupplemented control (Figure 2(b)).
The culture of DPSC in the presence of greater than 
2.5 µg/mL DDM significantly reduced apoptotic caspase 3 
activity compared to the unsupplemented (0 µg/mL) con-
trol cultures (Figure 3(a)). This effect was not apparent 
when cells were supplemented with DDM-neg at these 
concentrations; indeed at 5 µg/mL, apoptotic caspase 3 
was significantly increased compared to the unsupple-
mented culture (p < 0.001). At concentrations 1.25–0.08 µg/
mL DDM, there was no significant difference on the level 
of apoptotic caspase 3 compared to unsupplemented con-
trol. Conversely, at lower concentrations of 0.04–0.01 µg/
mL, there appeared to be an increase in caspase 3 activity 
compared to levels at similar time points for 0 µg/mL. 
These data are partially supported by the analysis of 
mRNA which also indicated a substantial reduction in cas-
pase 3 mRNA and considerable increase in cell survival 
protein Akt1 in the presence of 1 µg/mL DDM at 24 h 
(Figure 3(b)). Expression levels resumed to basal unsup-
plemented levels by 72 h.
Influence of DDM on DPSCs migrating into 
collagen gels
Confocal microscopy of phalloidin-FITC-stained cells 
indicated that DPSCs were able to migrate into the colla-
gen gels to a depth of approximately 50 µm, regardless of 
whether the gels contained DMP, DMP-neg or were unsup-
plemented (Figure 4(a)). For all gels, the cells appeared to 
be evenly distributed throughout (Figure 4(b)). Average 
cell counts and standard deviations were obtained from 
five images obtained from three separate gels. The results 
obtained indicate that supplementation with either DDM 
or DDM-neg does not enhance or impede cell migration 
through the surface layers of the collagen gels (Figure 
4(c)). After 24 h, the presence of neither 1 nor 10 µg/mL 
DDM did not significantly increase the number of cells 
entering the gel compared with the unsupplemented con-
trol (p > 0.05). Similar results were obtained for DDM-neg 
(p > 0.05). At 72 h, an increase in cell counts was observed, 
possibly through continued migration or proliferation of 
the cells in the gels, but again, no significant difference 
was seen due to the supplementation of the gels with DDM 
or DDM-neg.
Influence of DDM on osteoblast differentiation
The presence of 1 µg/mL DDM in the culture media stimu-
lated the expression of mRNA levels for OPN and alkaline 
phosphatase (Figure 5). qPCR analysis indicated signifi-
cant increases for osteogenic markers, OPN and alkaline 
phosphatase at all days examined during osteogenic induc-
tion (p < 0.05 for alkaline phosphatase at all time points 
and p < 0.001 for OPN for culture time greater than 
10 days). These data are supported by Alizarin Red stain-
ing which indicated, in the presence of DDM, the initial 
Figure 2. Stimulatory effect of DDM on the expansion of 
hFNA3 clonal cell numbers during culture over 72 h: (a) cells 
were visualised by staining with crystal violet, and average cell 
counts and corresponding SEMs were obtained (n = 9). As 
a negative control, DDM was denatured to produce DDM-
neg, where bioactivity was observed to be abolished, and 
(b) concentrations reported for DDM-neg are equivalent to 
the starting concentration of DDM prior to denaturation 
treatment.
*p < 0.05, **p < 0.01 and ***p < 0.001.
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formation of mineral deposition following culture for 
5 days and the clear formation of mineralised nodules fol-
lowing 20 days in culture.
Discussion
Protein analysis of DDM suggests that it contains a 
range of growth factors and matrix proteins which have 
a bioactive potential for stimulating mineralised tissue 
repair. While this has been confirmed through in vivo 
studies, this study is the first to confirm bioactivity on a 
clonal MSC population derived from human dental pulp. 
This study specifically identified that DDM has the 
potential to stimulate cell expansion, reduce apoptosis 
and induce synthesis of a mineralised matrix, with all 
responses observed to be concentration dependent. 
Significantly, these results indicate that physiological 
levels of bioactive components within the DDM are 
capable of stimulating the respective cellular events 
associated with reparative dentine formation allowing 
further confirmation of in vivo histological studies and 
proposals derived from the biochemical analysis of the 
dentine.
In vitro phenotypic data derived from recent studies of 
clonal populations of MSCs isolated from bone marrow, 
umbilical cord and dental pulp tissue have led to the pro-
posal that MSCs resident in connective tissue represent a 
heterogeneous population which can best be presented as a 
hierarchical structure with respect to differentiation poten-
tial and proliferative capacity observed.27,31–33 At the head 
of this structure are the more immature MSCs, most 
recently derived from the mother stem cell which have a 
high proliferative capacity and appear multi-potent in 
nature. As these transit-amplifying (TA) cells rapidly pro-
liferate, they are proposed to become progressively more 
bi-potent and subsequently unipotent for osteo- (osteode-
nine-like), adipo- or chondrogenic lineages with limited 
proliferative capacity.31–33 The heterogeneous population 
in vivo is proposed to contain the complete hierarchical 
organisation of cells, and donor variability in heterogene-
ity has the potential to impact on the clarity of the results 
obtained. Which MSC population contributes directly to 
reparative dentine formation is not fully clear. Implantation 
of mouse dental pulp clonal MSC populations into man-
dibular incisors suggest that those MSCs which demon-
strate high multi-potential phenotype in vitro contribute 
better to reparative dentine formation in vivo compared 
with the lineage-restricted cells.34 In situ injury studies 
tracking the different MSC phenotypes have, however, 
suggested that the lineage-restricted TA cells with pre-
sumed unipotency for osteogenesis or osteodentine forma-
tion, are the first to differentiate into new odontoblast-like 
cells following cavity-induced injury, with these cells 
replenished by the more multi-potent cells.35 Both studies 
would indicate an importance for the multi-potent cell, and 
consequently, this study utilised a clonal cell line of 
defined immature mesenchymal physiognomies, which 
demonstrated an extensive proliferative lifespan and had 
not become lineage restricted. We are, thus, confident that 
the bioactivity of DDM was assessed on a well-character-
ised multi-potent cell population which had no preferential 
differentiation for osteogenic or odontogenic lineages. 
Expansion of the cells to 106 PDs resulted in the loss of all 
Figure 3. (a) Anti-apoptotic effect of DDM on the DPSC 
clonal cells as demonstrated by reduced caspase 3 activity. 
A similar effect was not observed following supplementation 
with DDM-neg, and apoptosis was stimulated in the presence 
of the degraded products at 5 µg/mL. (b) RT-PCR for mRNA 
expression levels of caspase 3 and the cell survival factor Akt1 
confirm the results of the caspase assay. Means and SEMs for 
the caspase 3 luminescence assay are calculated from n = 9.
*p < 0.05, **p < 0.01 and ***p < 0.001.
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except for Notch 1 and 3 and Jagged 1 and 2. The change 
in expression profile indicates the loss of the immature 
stem cell characteristics (supported by the loss of embry-
onic and MSC markers), correlating with a loss in multi-
potency at later PDs (results not shown). Notch 2 is not 
expressed in the pulp of healthy adult teeth, but expression 
is up-regulated during dentine repair, where it is proposed 
to have a role in enhancing survival of uncommitted pre-
cursors and intermediate-stage cells within the sub-
odontoblast region.36 The assessment of DDM bioactivity 
was, thus, performed using clonal cells at a low passage 
(24 PDs) where the regenerative potential of high prolif-
eration and multi-differentiation capacity was optimal.
Dentine regeneration occurs within the mature adult 
tooth either as a result of caries or trauma resulting in sig-
nificant loss of the primary dentine (formed during embry-
onic tooth development) and hence the loss of the 
embedded mature odontoblasts cells which maintain the 
vitality of the tissue. The regeneration process involves the 
migration of MSCs to an area below the site of injury, fol-
lowed by their cellular expansion and subsequent differen-
tiation to odontoblast-like cells that produce a mineralised 
‘barrier’ tissue directly below the devitalised dentine. 
Unlike the original primary or ‘orthodentine’ which has a 
defined tubular structure, the synthesised regenerative 
dentine has the histological appearance of an amorphous 
mineralised matrix with sporadic cellular inclusions. 
Biochemically, it shows many similarities to osseous tis-
sue rather than primary dentine, with the prominent pres-
ence of bone matrix proteins of BSP and OCN and the 
notable absence of dentine phosphoprotein.37 The molecu-
lar regulation of the reparative dentine formation is still 
not fully established but is reported to involve many of the 
growth factors that control intramembraneous ossification. 
Within this study, bioactive factors within the DDM across 
the concentration range of 0.001–10 µg/mL were shown to 
stimulate expansion of the clonal DPSCs. The effect was 
concentration dependent with 10 µg/mL demonstrating the 
greatest potency. At the higher concentrations of 5–10 µg/
mL, the DDM also appeared to aid cell survival through a 
decrease in the levels of caspase 3 and increase in the 
expression of the serine threonine kinase, Akt1, which is 
reported to inactivate apoptotic mechanisms within cells.38 
Platelet-derived growth factor (PDGF), identified in DDM, 
has been shown to activate the Akt1 and Akt2 pathways in 
promoting this anti-apoptotic activity,39 but additionally, 
studies have indicated that the abundant matrix component 
of dentine phosphoprotein also has an anti-apoptotic activ-
ity.40 The observed expansion in cell numbers is also likely 
to be attributable to a range of growth factors with known 
mitogenic properties for MSCs and bone forming cells, 
including TGF-β1, PDGF, FGF and IGF-I. Significantly, 
the synergistic action of these ‘cocktails’ of growth factors 
collectively facilitates greater signalling power at substan-
tially lower concentration, compared with the studies that 
have examined the effects of a single growth factor added 
exogenously. These growth factor ‘cocktails’ are also 
known to play important active roles during early events of 
reparative mineral tissue formation.41 Within this study, 
DDM was shown to possess an osteogenic potency, with 
the deposition of a mineralised matrix and a concomitant 
increase in OPN and alkaline phosphatase achievable at 
concentrations of 1 µg/mL. Growth factors present during 
early healing events are proposed to subsequently stimu-
late osteogenesis. For example, TGF-β1 has also been pro-
posed to initiate signalling for BMP synthesis by 
osteoprogenitor cells, effecting osteoblast differentiation.42 
The presence of BMP-2, BMP-4 or BMP-7 will also be 
contributing factors. Indeed, reparative responses have 
been reported for TGF-β1,43 BMP-7,44 BMP-245 and FGF/
Figure 4. DDM has no stimulatory or impeding influence on the migration of DPSC clonal cells into collagen gels: (a) typical confocal 
data derived from Z-stacks obtained from confocal microscopy images of gels indicating the ability of the cells to migrate into the 
collagen matrix to a depth of 50 µm; (b) collagen gels were also examined by fluorescence microscopy, with cells viewed from the top 
surface and cell count, using ImageJ, and are shown graphically for the respective experimental and control groups after 24 and 72 h in 
culture; and (c) means and SEMs are calculated from n = 15; statistical analysis indicated no significant difference between gels.
Lee et al. 11
IGF46 when examined in various in vivo or ex vivo wound 
repair models. There is increasing recognition in the litera-
ture that other ECM proteins play a role in stimulating 
mineralised tissue repair processes. The SLRPs decorin 
and biglycan can bind to growth factors and cytokines 
including TGF-β14,15 and BMP-216 and have been pro-
posed to play major roles in sequestering growth factors 
to the matrix, protecting them from proteolysis and mod-
ulating growth factor activity14 Biglycan has been pro-
posed roles during early proliferative and osteogenic 
differentiation stages17 and can directly interact with cell 
surface receptors to enhance BMP-2-induced osteoblasts.16 
Similarly, osteogenic signalling roles, leading to stimula-
tion of reparative dentinogenesis using in vivo injury mod-
els, have been proposed for matrix proteins BSP and 
MEPE.47 DDM matrix may, therefore, provide enhanced 
osteogenic potency not only via synergistic action of com-
binations of growth factors, at physiological levels, but also 
by the contributory interaction with other ECM proteins.
The application of DDM for regenerative medicine 
would require its incorporation into a scaffold into which 
cells would be able to migrate efficiently. In an attempt to 
mimic this situation, the migration of the DPSCs into col-
lagen gels containing 1 or 10 µg/mL DDM was assessed. 
Figure 5. The ability of DDM to induce osteogenesis: (a) mRNA expression of osteogenic markers osteopontin (OPN) and 
alkaline phosphatase (ALP) as determined by quantitative PCR, and (b) the appearance of Alizarin Red staining mineral deposits and 
mineralised nodules in the presence and absence of DDM. Means and SEMs are calculated from n = 6.
*p < 0.05, **p < 0.01 and ***p < 0.001.
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This scenario could be considered to mimic the in vivo 
migration of DPSCs through a collagenous pulpal matrix 
infused with DDM. The presence of DDM did not appear to 
adversely affect the behaviour of the DPSCs, and they were 
able to penetrate to an approximate depth of 50 µm into the 
gel. The migratory process would have required degrada-
tion of the collagen matrix which could be facilitated by 
metaloproteinases released by the DPSC during migration, 
although a proteolytic contribution from MMPs reported as 
present in DDM19 is also possible. Cell numbers were 
higher after 72 h in culture, which could partially be attrib-
utable to maintenance of cell proliferative activity during 
culture. Within this experimental set-up, we could not con-
firm chemotactic properties of DDM for MSCs, which 
could be expected due to the previous purported presence 
of factors such as TGF-β1, PDGF and IGF-I and IL-1, IL-6 
and tumour necrosis factor-alpha (TNF-α).12,19 This may be 
due to the higher concentrations of DDM employed in this 
study as cells often first sense chemotactic gradients at 
much lower levels at sites within the tissue remote to the 
release of the stimuli. The results, however, clearly indicate 
that the presence of DDM appeared to have no negative 
effect towards cell migration, repelling cells, thus support-
ing its potential for regenerative therapy applications.
In summary, the DDM components are able to stimulate 
cell expansion, promote cell survival through reduced 
apoptosis and promote osteogenic or odontogenic differ-
entiation. Significantly, the results presented herein indi-
cate that bioactive proteins in DDM facilitate signalling at 
physiological concentrations in stimulating these sequen-
tial wound healing events associated with mineralised tis-
sue repair. Enhanced effects on cell proliferation and cell 
survival were abolished when the DDM was degraded 
with proteases and collagenase, indicating that bioactivity 
is achieved through intact proteins extractable from den-
tine. The study provides further support for a potential for 
the incorporation of DDM into scaffolds to stimulate den-
tine bridge formation below dental restorations. Close par-
allels with osteogenesis would imply application of the 
knowledge herein to the wider field of bone regeneration, 
where the major clinical challenges are accelerating heal-
ing and restoring effective signalling efficiency where 
bone repair is compromised.
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